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Summary Now that most patients with Wilms' tumour are cured, it is practicable to study the long-term
morbidity of their treatment and use this information to reduce treatment sequelae in the future. In this study
we evaluate the size and function of the remaining kidney in 53 survivors of Wilms' tumour with a mean off
treatment follow-up of 13 years. There was evidence of renal dysfunction in 17 (32%), including ten (19%)
with a low GFR (<80 ml/min/1.73 m2 SA), six (11%) with hypertension and five (9%) with increased urinary
albumin excretion. Measurements of renal size showed 'good' renal compensatory hypertrophy in only 55% of
patients. 'Good' refers to renal size of more than 2 s.d. above the mean renal length for children with two
kidneys. There were no correlations between GFR, renal size, blood pressure, microalbuminuria or type of
treatment. However, children less than 24 months at diagnosis and children receiving chemotherapy with
radiation doses to remaining kidney of more than 1200cGy had a worse renal prognosis.
Patients whose Wilms' tumour is diagnosed in infancy should have careful long-term follow-up of renal
function and size. Older patients may safely be followed up less often, unless their remaining kidney was
received > 1200 cGy.
More than half a century after the introduction of nephrec-
tomy for the treatment of unilateral Wilms' tumour (Priestly
et al., 1942), there is little published data concerning growth
and function of the remaining kidney. Several studies have
shown that there is compensatory renal growth in patients
treated for Wilms' tumour with multimodality therapy
(Walker et al., 1982; Luttenegger et al., 1975; Dinkel et al.,
1988), but less than in children who have nephrectomy for
non-malignant conditions. There are few reports of both
renal growth and function in long-term survivors of Wilms'
tumour and the number of patients in these studies is small
(Wikstad et al., 1986; Makipernaa et al., 1991).
The issue is of particular current interest because of recent
reports of delayed morbidity in patients with renal agenesis
or after nephrectomy for non-malignant conditions. Some of
these patients have presented with hypertension and protein-
uria due to focal glomerulosclerosis (Watnick et al., 1988;
Kiprov et al., 1982), possibly the consequence of hyperfiltra-
tion-induced damage to the remaining glomeruli (Zucchelli et
al., 1983; Hostetter, 1984). There are also case reports de-
scribing glomerulosclerosis in long-term survivors of Wilms'
tumour (Welch et al., 1986; Scully et al., 1985).
These findings, if substantiated, would have implication for
the design of new treatment protocols and long-term follow-
up strategies. The aim of our study was to measure renal
growth and function in long-term survivors of unilateral
Wilms' tumour and to identify risk factors for renal damage.
Patient characteristics and methods
Eighty-two consecutive survivors of Wilms' tumour, Stage
I-IV, diagnosed between 1970-1980 at the centres, Hospital
for Sick Children and St. Bartholomew's Hospital, London,
were eligible for the study which ran from August 1988 to
April 1990. Fifty-four patients agreed to participate. One was
later withdrawn from analysis as, 8 years after the diagnosis
of a right sided Wilms' tumour, she needed surgical treat-
ment for a left sided adrenal phaeochromocytoma which may
have contributed to her renal dysfunction.
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Twenty-six patients were female. The mean age at diag-
nosis was 3.4 ± 0.17 years (range 0.6-10.2), approximately
the median age for Wilms' tumour at diagnosis (Green et al.,
1979). Mean follow-up time was 12.9 ± 3.0 years (range 7.8-
19) with a mean age at time of study 16.1 ± 3.6 years (range
9.5-24.1). Twenty-eight were post-pubertal and two girls had
babies of their own during the study period. One patient had
hemihypertrophy but otherwise there were none of the con-
genital abnormalities sometimes seen in Wilms' tumour
patients. Tumour stage and treatment are shown in Table I.
Many had been treated in the Medical Research Council 1st
and 2nd Wilms' Tumour Trials and three patients were in the
1st United Kingdom Childrens Cancer Study Group Wilms'
Tumour Study.
Twenty-five patients (47%) had stage I disease. The treat-
ment for Stage I disease varied over the period of the study:
four patients had a nephrectomy only because they were aged
less than 18 months at diagnosis. One child was treated with
surgery and renal bed radiotherapy alone and nine with
nephrectomy and chemotherapy (vincristine or actinomycin-
D or both for 6-12 months) without irradiation. The
remainder had both abdominal radiotherapy and chemo-
therapy. The 28 stage II-IV patients were all irradiated and
received a combination of two, three, or four cytotoxic drugs
(vincristine, actinomycin, ± doxorubicin ± cyclophosphamide)
over 6-22 months. The radiation dose to the surviving
kidney was dependant on the field and kidney shielding. By
reviewing all simulator films and treatment sheets, the dose
of radiation to the remaining kidney was calculated for each
patient. Twenty-three patients received less than 1200cGy
(130-1200) and 17 children received doses ranging from
1200-1720 cGy.
The 28 patients not studied had a comparable median age
at diagnosis of 3.3 years (range 0.5-12). The stage distribu-
tion were similar with 44% patients with stage I disease.
More patients were in treatment Group I (30%) and Group
III (48%) than the study group but detailed radiation doses
were not calculated.
Each patient was admitted as a day case for the investiga-
tions. A full blood count, electrolytes, urea and creatinine
were measured. Glomerular function was assessed in two
ways. The glomerular filtration rate (GFR) was measured
from the plasma clearance of 51-chromium diaminotetra-
acetic acid (5"Cr EDTA) calculated from plasma samples at 2
and 4 h and corrected to 1.73 m2 surface area (SA) (Chantler
et al., 1972). Microalbuminuria (Viberti et al., 1982) was used
as a sensitive measure of renal glomerular damage. An over-
night urine specimen was obtained and the urine albumin
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Table I Study patients' stage and treatment n = 53
Nephrectomy Nephrectomy Nephrectomy
chemotherapy chemotherapy chemotherapy Nephrectomy
Stage No. Nephrectomy radiotherapy 1 radiotherapy 2 radiotherapy 1
I 25 4 9 11 0 1
II 10 - - 5 5 -
III 13 - - 5 8 -
IV 5 - - 1 4 -
Radiotherapy 1 = < 1200 cGy; Radiotherapy 2 = > 1200 cGy.
concentration measured by radioimmunoassay and expressed
as a ratio to urinary creatinine concentration (UA/UC)
measured in mgmmol'l. The values were compared with
those from 77 normal children (Gibb, 1990). Albumin was
measured using a commercially available kit with a sensitivity
of 0.5 mg 1`. The ratios were log transformed before statis-
tical analysis; results were expressed as the geometric mean
and range ( ± s.d.) calculated on logged data.
An aliquot of the overnight urine specimen from patients
with microalbuminuria was tested for abnormalities reflecting
renal tubular dysfunction. Retinol binding protein (RBP) is a
low molecular weight protein freely filtered by the glomerulus
and reabsorbed by the proximal tubule. It was measured in
urine by an enzyme linked immunosorbent assay using rabbit
antisera (Gibb, 1990) and expressed as a ratio to creatinine.
Blood pressure was measured on three occasions by two
observers (EY, GL) with patients on bedrest. A random zero
sphygmomanometer was used to reduce observer bias. The
nearest two values were averaged and a standard deviation
scores (SDS) calculated using Task Force on Blood Pressure
Control in Children 1987 data matched for sex and age (Task
Force Member, 1987). The mean blood pressure SDS were
compared to zero using an unpaired t-test.
Plasma renin activity was measured in venous blood after
the patient had 2 h bedrest by radioimmunoassay of angio-
tensin I generated (Dillon et al., 1975). A midstream urine
was obtained for urine analysis and culture.
Kidney size was measured using a Siemens SL2 ultrasound
machine with a 3.5 or 5 megahertz probe. The patients were
in the prone position and three readings were taken in each
plane. The renal length standard deviation scores were cal-
culated using Dinkel's data for renal length in healthy cont-
rols with two kidneys matched for kidney laterality and
patient height (Dinkel et al., 1985). Good renal compen-
satory hypertrophy was defined on kidneys measuring more
than two standard deviation above the mean for the controls.
A similar study (Breatnach, F., unpublished) had been
performed between 1980-1982 on 43 of the 53 children
reported here. The method of GFR estimation was similar
and therefore direct comparison was valid but methods of
blood pressure estimation and renal size measurement were
not considered comparable between the two studies. Para-
meters were compared with the t-test and correlations were
investigated using linear regression anaylsis.
Results
One patient had E. coli urinary tract infection on the study
day; and her data were included in this analysis. Full blood
count, electrolytes, urea and creatinine were normal in all
patients.
Glomerularfunction
The mean GFR estimated from the plasma clearance of 5'Cr
EDTA was 89.9 ± 13.7 ml/min/1.73 m2 SA (Figure 1). Ten
patients had GFR<80 ml/min/1.73 m2 SA. Forty-three of
the patients had, as described been studied between 1980-
1982 and there was good correlation between the GFRs
(Figure 2 P<0.001), the mean GFR change was + 11.2ml/
min/1.73 m2 SA, (± 11.3).
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Figure 2 Glomerular filtration rate 1st vs glomerular filtration
rate 2nd study.
The geometric mean UA/UC for the Wilms' tumour
patients was 0.45 (range 0.09-23.26), not significantly
different from the mean of the controls 0.32 mgmol-' (range
0.05-1.95) (Viberti et al., 1982). Increased albumin excretion
was detected in five children (range 2.1-23.26 mg ml-).
These five children, one of whom had developed diabetes
mellitus six years before the study, were screened for tubular
proteinuria (RBP) but no increase was detected.
Bloodpressure andplasma renin activity
Six children (11%) were either hypertensive (Systolic blood
pressure SDS> 2.0) or on treatment for hypertension. The
mean systolic blood pressure SDS excluding the two children
who were on antihypertensive treatment was 0.84 ± 1.03
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Figure 5 Frequency histogram of renal length SDS.
Children who received no radiation (13 patients Group I),
* children receiving radiation of < 1200 cGy (23 patients
-* Group II), and children receiving > 1200cGy (17 patients
Group III) were compared (Table II). There were no signi-
ficant differences in blood pressure but in Groups I and III
the mean GFR was significantly lower than in Group II
Normals Wilms' (P<0.05). Mean renal size in Group III was also signi-
ficantly less than in Group II (P<0.05). Group III had a
e 3 Urinary albumin/urinary creatinine ratios in controls significantly higher mean UA/UC value than the 77 normal
tudy patients. controls (P<0.01).
There was evidence of renal dysfunction in the children
with inadequate renal size (<2 s.d.) compared with the
remaining children. Significantly more children with small
kidneys have lower GFR (P<0.02) although the differences
in the mean GFR are not significant (Table III).
The most significant finding, however, was age at time of
n = 53 nephrectomy (P<0.01). Children less than 24 months old at
time of surgery had poor subsequent renal growth (Figure 6)
and in comparison with older children there was a trend to
have low mean GFR and higher mean systolic BP SDS
(Table IV). Yet these children have had less treatment for
Wilms' tumour. In four, nephrectomy alone was performed
ii and of the seven who received chemotherapy six received
Group II treatment with only one child receiving 1200cGy to
the remaining kidney.
-2 -1.5 -0.5 0.5 1 1.5 2 2.5 3 4 One child from Group II with a high GFR 123 ml/min/
1.73 m2 SA had microalbuminuria. This child was not hyper-
Systolic BP SDS tensive, but may be showing early signs of hyperfiltration
Mean Systolic BP SDS 0.84 (+/-1.03) syndrome.
Figure 4 Frequency histogram of systolic BP SDS.
Discussion
(range - 1.80 to +3.80) (Figure 4). The mean diastolic blood
pressure SDS was 1.15 (± 1.11) (range -1.4 to +4.3). Both
systolic and diastolic BP SDS were significantly greater than
zero (t = 7.3 P<0.001). Of 51 children tested, plasma renin
activity was abnormal in three children but one child, was
considered not to have been on complete bedrest, and neither
of the other two were hypertensive.
Renal size
Renal length ranged from -0.55 to 5.80 (Figure 5) with a
mean renal length SDS of 2.19 ± 1.52 (range -0.55 to 5.80)
(Figure 5). Renal length scores did not correlate with time
since nephrectomy. Adequate post-nephrectomy compensa-
tory renal hypertrophy (renal length >2 s.d.) was considered
to have occurred in 29 children. In the other 24 there was
'inadequate' renal growth (<2 s.d.).
No overall correlation was found between renal length,
GFR, microalbuminuria, systolic blood pressure or type and
intensity of treatment.
These patients represented 67% of all the children presenting
with unilateral Wilms' tumour to two specialist oncology
centres between 1970-1980. There was no known selection
bias, the refusal ofpatients or parents to be studied being the
main cause for exclusion.
Stage I disease was diagnosed in 47% of patients, a higher
proportion than would be expected at diagnosis, reflecting
the better survival of these children (Walker et al., 1982).
This study is the largest to investigate both renal size and
function in patients more than ten years from treatment.
Seventeen (32%) of patients, with a mean follow-up period
of 13 years had evidence of renal dysfunction, in addition 14
patients had only small kidneys. Two-thirds of all the
patients had received less than 600 cGy to the remaining
kidney.
Nine of the ten patients with low GFR had also been
tested 8 years previously. All of them had a GFR<85ml/
min/1.73 m2 SA at that time. Overall, the GFR has increaed
between the two studies (Figure 2). The mean GFR of
90 ml/min/1.73 m2 SA is in line with other studies after
nephrectomy for non-malignant and malignant conditions
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Table II Results in relation to treatment groups
Group I P value Group II P value Group III
Radiotherapy None < 1200cGy > 1200 cGy
No. 13 23 17
Mean renal length SDS (±s.d.) 1.9 (±1.8) 2.8 (± 1.3) p<O.O5b 1.7 (±1.5)
No. of patients SDS<2 8 7 9
Mean GFR ml/min/1.73 m2 SA (±s.d.) 86.5 (± 11.1) P<0.05a 95.0 (± 11.7) p<O.OSb 84.5 (± 16)
No. of patients GFR<80 ml/min/1.73 m2 SA 4 2 4
Mean systolic BP SDS (±s.d.) 1.1 (±0.8) 0.9 1.0) 0.8 (±0.9)
No. of patients SDS>2 or on treatment for 1 1 4
hypertension
Geometric mean urinary albumin/ creatinine 0.29 0.41 0.70
ratio mmol/mg (range) (0.1-1.21) (0.09-7.26) (0.11-23.26)
Abnormal urinary albumin/creatinine ratio 0 3 2
apvaluebetweenGroup IandII;bpvalue betweenGroupII and III. No othersignificantdifferences werefound.
Table III Results in relation to size of kidney
Renal length <2 s.d. >2 s.d. P value
No. of patients 24 29
Mean GFR ml/min/1.73 m2 SA (±s.d.) 87 (± 13) 93 (± 14) NS
GFR<80 ml/min/1.73m2 SA 8 2 <0.02
Mean systolic BP SDS (± s.d.) 1.1 (±0.9) 0.8 (± 1.0) NS
Systolic BP>2 SDS or on treatment for hypertension 4 2 NS
Geometric mean urinary albumin/creatinine mmol/mg-' 0.47 0.42 NS
(range) (0.12-7.26) (0.09-23.26)
Abnormal urinary albumin/creatinine ratio 6 7 NS
Age at nephrectomy
<24 months 13 5 <0.01
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Figure 6 Renal length vs height.
* +2SD El < 24/12
(Walker et al., 1982; Robitaille et al., 1985) Ten (19%)
patients had poor renal clearance and will need long term
surveillance.
There has been controversy regarding the risk of a hyper-
filtration syndrome resulting in a glomerulosclerosis (Kiprov
et al., 1982; Zucchelli et al., 1983; Robitaille et al., 1985;
Novick et al., 1991) in patients who have had nephrectomy.
Novick et al. suggested proteinuria was inversely propor-
tional to the remaining functional renal mass and patients
with a reduction of more than 75% were at particular risk.
Microalbuminuria is a sensitive index of glomerular damage.
Five patients had increased protein excretion of glomerular
origin and all of them had received irradiation (240-1704
cGy). One adolescent patient 10 years off treatment had
increased his GFR by 24% in 8 years to 123 ml/min/m2 SA
(>2 s.d. above the mean for the Wilms' cohort); although
his kidney length was 2.2 SDS, he may be showing features
of hyperfiltration. Of the remaining four patients, two had
small kidneys and a low GFR and one child had diabetes
mellitus, a known cause of increased protein excretion (Gibb
et al., 1989).
Six patients (11%) were hypertensive or on treatment for
1 fi
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Table IV Results in relation to age at nephrectomy
Age at nephrectomy <24/12 >24/12
No. of patients 18 35
Mean renal length SDS (± s.d.) 1.7 (± 1.3) 2.4 (± 1.6)
Renal length <2 s.d. 13 11
Mean GFR ml/min/1.73 m2 SA (± s.d.) 88.8 (± 10.7) 90.5 (± 14.8)
GFR <80 ml/min/1.73m2 4 6
Mean systolic BP SDS (± s.d.) 1.13 (±0.75) 0.98 (±0.84)
Systolic BP>2 s.d. or on treatment for
hypertension 2 4
Geometric mean urinary albumin/ 0.34 0.51
creatinine ratio mmol/mg (range) (0.1-3.2) (0.09-23.26)
Abnormal urinary albumin/creatinine
ratio 1 4
hypertension. Our cohort had elevated systolic and diastolic
BP SDS. Significantly greater than zero (t = 7.3, P<0.001).
Kantor et al. (1989) studied 119 adult survivors ofchildhood
renal tumours and concluded that hypertension was not a
complication of Wilms' tumour or its treatment. However,
there was no standardisation of the techniques used for
blood pressure measurements in their study.
Ultrasound was used to measure renal length because it is
non-invasive, requires no contrast medium and has minimum
inter-observer error. Earlier studies all used intravenous
pyelograms and comparison of kidney size with L -L5
length, an inaccurate measurement in patients receiving
radiotherapy. In normal children renal length is shown to
correlate with height (Dinkel et al., 1985) and so, to evaluate
our data on children investigated at differing ages, we cal-
culated a renal length SDS from published data on height
and renal length in normal children. This method is also
obviously flawed because 40 children received radiation to
the lumbar spine and four also had thoracic spine irradiation
for pulmonary metastases. Shalet et al. (1987) studied the
effect of radiation on spinal growth of patients receiving
craniospinal radiation and calculated a maximum loss of
9 cm. The value was dependent on age at time of radiation.
Silber et al. (1990) developed an equation to calculate height
loss which took into account dose, age at the time of radia-
tion and length of spine involved. Using the equation our
patients' estimated height loss was 6-8 cm i.e. approximately
3% of their height which we felt would only marginally
overestimate their renal length SDS. Poor compensatory
renal growth (<2 s.d.) was associated with low GFR and
may be a useful non-invasive follow-up screening test to
identify patients at risk.
The various treatment modalities appear not to influence
late morbidity. Patients receiving chemotherapy and renal
bed or hemiabdominal radiation appear to fare better than
the children who receive no radiation or whole abdominal
radiation. Other workers (Walker et al., 1982; Luttenegger et
al., 1975; Jereb et al., 1973) have found no relationship
between intensity of treatment and GFR or renal size. The
no radiation group (I) consists mostly (Zucchelli et al., 1983;
Green et al., 1979) of children <24 months at diagnosis and
these young children have significantly smaller kidneys and
sometimes have other forms of nephropathy. Wilms' tumour
and genito-urinary abnormalities have been associated with
nephropathy in the form of DRASH syndrome (Jadresic et
al., 1990). It could be speculated that children with Wilms'
tumour presenting early in life may have a predisposition to
glomerular pathology linked to chromosomal deletions near
the Wilms' gene/s. Mitus (Mitus et al., 1969) in her study of
108 patients, mentions four Wilms' survivors who had no
radiation of whom three had low GFR with two of the three
receiving no chemotherapy. Their ages were not stated but
one wonders whether they were young at diagnosis. There
have also been anecdotal reports (Welch et al., 1986; Scully
et al., 1985) of patients less than 24 months at diagnosis
presenting with glomerulosclerosis at more than 10 years
from diagnosis. It is difficult to determine whether these
patients presented as a result of hyperperfusion or because of
pre-existing glomerular disease. Our data maybe suggests the
latter.
In summary, renal well-being cannot be guaranteed after
cure from Wilms' tumour. Around one-third of our patients
had evidence of renal impairment, apparently associated with
young age at diagnosis and radiation > 1200 cGy to the
remaining kidney. Larger intercentre studies are needed to
clarify these findings but, for the time being at least long-
term follow-up ofcured Wilms' patients is mandatory. Histo-
logical studies of the residual kidney tissue surrounding the
Wilms' tumour, may be particularly revealing. Partial neph-
rectomy and abandonment of whole abdominal radiation
may reduce renal morbidity in future generations.
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